Clin Orthop Surg.  2016 Jun;8(2):194-202. 10.4055/cios.2016.8.2.194.

Sarcopenia and Sarcopenic Obesity in Patients Undergoing Orthopedic Surgery

• Ji HM
• Han J
• Jin DS
• Suh H
• Chung YS
• Won YY

• KMID: 2412346
• DOI: http://doi.org/10.4055/cios.2016.8.2.194

Abstract

BACKGROUND
The purpose of this retrospective study was to determine the prevalence of sarcopenia and sarcopenic obesity among patients who underwent orthopedic surgery (OS).
METHODS
A total of 222 patients were reviewed immediately after or prior to OS. In the control group, 364 patients from outpatient departments (OPDs) who did not have any OS were enrolled. Whole-body dual-energy X-ray absorptiometry was used to analyze body composition. Skeletal muscle mass was adjusted for height squared, total body weight, and height and fat mass (residuals). Obesity was defined as body mass index (BMI) > 25.0 kg/m2.
RESULTS
The prevalence of sarcopenia in the OS group was 25.7%, 44.1%, and 26.6%, respectively, according to the 3 different criteria. The prevalence was significantly lower in the OPD group (6.0%, 33.1%, and 14.8%, respectively). The highest rates of sarcopenia with height-adjusted definition were seen in patients with a femoral neck fracture. In the multivariate analysis, factors associated with sarcopenia were male gender, older age, and lower BMI (odds ratio [OR]: 28.38, 1.03, and 1.83, respectively) when muscle mass was adjusted for height, whereas male gender, older age, and higher BMI were associated with sarcopenia (OR: 1.04, 2.57, and 1.83, respectively) when adjusted for weight. When residuals were used as a cutoff, decreased BMI and total hip bone mineral density (0.1 g/cm2) were independent risk factors associated with sarcopenia (OR: 1.09 and 1.05). The prevalence of sarcopenic obesity ranged from 1.8% to 21.2%.
CONCLUSIONS
Our study demonstrated a high prevalence of sarcopenia among OS patients.

Keyword

Sarcopenia; Prevalence; Retrospective studies; Body composition; Orthopedics

MeSH Terms

Aged
Aged, 80 and over
Body Composition
Female
Humans
Male
Middle Aged
Obesity/complications/*epidemiology
Orthopedic Procedures/*statistics & numerical data
Prevalence
Risk Factors
Sarcopenia/complications/*epidemiology

Figure

• 

  Fig. 1 Bar chart depicting the prevalence of type I and II sarcopenia among the different types of surgeries when adjusted for height (A), weight (B), and residuals (C). ASM: appendicular skeletal mass, TKR: total knee replacement, THR: total hip replacement.

Reference

1. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010; 39(4):412–423.

2. Hida T, Ishiguro N, Shimokata H, et al. High prevalence of sarcopenia and reduced leg muscle mass in Japanese patients immediately after a hip fracture. Geriatr Gerontol Int. 2013; 13(2):413–420.

3. Kaido T, Ogawa K, Fujimoto Y, et al. Impact of sarcopenia on survival in patients undergoing living donor liver transplantation. Am J Transplant. 2013; 13(6):1549–1556.

4. Kim JK, Choi SR, Choi MJ, et al. Prevalence of and factors associated with sarcopenia in elderly patients with end-stage renal disease. Clin Nutr. 2014; 33(1):64–68.

5. Kim SH, Kim TH, Hwang HJ. The relationship of physical activity (PA) and walking with sarcopenia in Korean males aged 60 years and older using the Fourth Korean National Health and Nutrition Examination Survey (KNHANES IV-2, 3), 2008-2009. Arch Gerontol Geriatr. 2013; 56(3):472–477.

6. Lee WJ, Liu LK, Peng LN, Lin MH, Chen LK. ILAS Research Group. Comparisons of sarcopenia defined by IWGS and EWGSOP criteria among older people: results from the I-Lan longitudinal aging study. J Am Med Dir Assoc. 2013; 14(7):528.e1–528.e7.

7. Lin CC, Lin WY, Meng NH, et al. Sarcopenia prevalence and associated factors in an elderly Taiwanese metropolitan population. J Am Geriatr Soc. 2013; 61(3):459–462.

8. Liu LK, Lee WJ, Liu CL, et al. Age-related skeletal muscle mass loss and physical performance in Taiwan: implications to diagnostic strategy of sarcopenia in Asia. Geriatr Gerontol Int. 2013; 13(4):964–971.

9. Miyakoshi N, Hongo M, Mizutani Y, Shimada Y. Prevalence of sarcopenia in Japanese women with osteopenia and osteoporosis. J Bone Miner Metab. 2013; 31(5):556–561.

10. Fukumoto S, Martin TJ. Bone as an endocrine organ. Trends Endocrinol Metab. 2009; 20(5):230–236.

11. Pratesi A, Tarantini F, Di Bari M. Skeletal muscle: an endocrine organ. Clin Cases Miner Bone Metab. 2013; 10(1):11–14.

12. DiGirolamo DJ, Kiel DP, Esser KA. Bone and skeletal muscle: neighbors with close ties. J Bone Miner Res. 2013; 28(7):1509–1518.

13. Park JH, Park KH, Cho S, et al. Concomitant increase in muscle strength and bone mineral density with decreasing IL-6 levels after combination therapy with alendronate and calcitriol in postmenopausal women. Menopause. 2013; 20(7):747–753.

14. Poole KE, Treece GM, Ridgway GR, Mayhew PM, Borggrefe J, Gee AH. Targeted regeneration of bone in the osteoporotic human femur. PLoS One. 2011; 6(1):e16190.

15. Baumgartner RN, Koehler KM, Gallagher D, et al. Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol. 1998; 147(8):755–763.

16. Janssen I, Heymsfield SB, Ross R. Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J Am Geriatr Soc. 2002; 50(5):889–896.

17. Newman AB, Kupelian V, Visser M, et al. Sarcopenia: alternative definitions and associations with lower extremity function. J Am Geriatr Soc. 2003; 51(11):1602–1609.

18. Rolland Y, Lauwers-Cances V, Cristini C, et al. Difficulties with physical function associated with obesity, sarcopenia, and sarcopenic-obesity in community-dwelling elderly women: the EPIDOS (EPIDemiologie de l'OSteoporose) Study. Am J Clin Nutr. 2009; 89(6):1895–1900.

19. Shepherd JA, Lu Y, Wilson K, et al. Cross-calibration and minimum precision standards for dual-energy X-ray absorptiometry: the 2005 ISCD Official Positions. J Clin Densitom. 2006; 9(1):31–36.

20. Kim YS, Lee Y, Chung YS, et al. Prevalence of sarcopenia and sarcopenic obesity in the Korean population based on the Fourth Korean National Health and Nutritional Examination Surveys. J Gerontol A Biol Sci Med Sci. 2012; 67(10):1107–1113.

21. Moreland JD, Richardson JA, Goldsmith CH, Clase CM. Muscle weakness and falls in older adults: a systematic review and meta-analysis. J Am Geriatr Soc. 2004; 52(7):1121–1129.

22. Visser M, Goodpaster BH, Kritchevsky SB, et al. Muscle mass, muscle strength, and muscle fat infiltration as predictors of incident mobility limitations in well-functioning older persons. J Gerontol A Biol Sci Med Sci. 2005; 60(3):324–333.

23. Chang MJ, Kang YG, Chang CB, Seong SC, Kim TK. The patterns of limb length, height, weight and body mass index changes after total knee arthroplasty. J Arthroplasty. 2013; 28(10):1856–1861.

24. Kang BJ, Ha YC, Hwang SC, Lee YK, Koo KH. Midterm results of large diameter Biolox forte ceramic head on delta ceramic liner articulation in total hip arthroplasty. J Arthroplasty. 2014; 29(12):2412–2414.

25. Lee YK, Ha YC, Yoon BH, Koo KH. Incidence of second hip fracture and compliant use of bisphosphonate. Osteoporos Int. 2013; 24(7):2099–2104.

26. Kim TN, Yang SJ, Yoo HJ, et al. Prevalence of sarcopenia and sarcopenic obesity in Korean adults: the Korean sarcopenic obesity study. Int J Obes (Lond). 2009; 33(8):885–892.

27. Figueiredo CP, Domiciano DS, Lopes JB, et al. Prevalence of sarcopenia and associated risk factors by two diagnostic criteria in community-dwelling older men: the Sao Paulo Ageing & Health Study (SPAH). Osteoporos Int. 2014; 25(2):589–596.

28. Estrada M, Kleppinger A, Judge JO, Walsh SJ, Kuchel GA. Functional impact of relative versus absolute sarcopenia in healthy older women. J Am Geriatr Soc. 2007; 55(11):1712–1719.

29. Lang T, Cauley JA, Tylavsky F, et al. Computed tomographic measurements of thigh muscle cross-sectional area and attenuation coefficient predict hip fracture: the health, aging, and body composition study. J Bone Miner Res. 2010; 25(3):513–519.

30. Pahor M, Manini T, Cesari M. Sarcopenia: clinical evaluation, biological markers and other evaluation tools. J Nutr Health Aging. 2009; 13(8):724–728.